• 1
    Liotta LA. Tumor invasion and metastasis-role of the extracellular matrix. Rhoads Memorial Award Lecture. Cancer Res 1986; 46: 17.
  • 2
    Nicolson GL. Metastatic tumor cell interactions with endothelium, basement membrane and tissue. Curr Opin Cell Biol 1989; 1: 10091019.
  • 3
    Tryggvason K, Höyhtyä M, Salo T. Proteolytic degradation of extracellular matrix in tumor invasion. Biochim Biophys Acta 1987; 907: 191217.
  • 4
    Nakajima M, Irimura T, Nicolson GL. Basement membrane degradative enzymes and tumor metastasis. Cancer Bull 1987; 39: 142149.
  • 5
    Collier IE, Wilhelm SM, Eisen AZ, Marnier BL, Grant GA, Seltzer JL, Kronberger A. et al. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem 1988; 263: 65796588.
  • 6
    Fidler IJ, Nicolson GL. The process of cancer invasion and metastasis. Cancer Bull 1987; 39: 126131.
  • 7
    Barsky SN, Siegal G, Jannotta F, Liotta LA. Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest 1983; 49: 140148.
  • 8
    Kalebic T, Garbisa S, Glaser B, Liotta LA. Basement membrane collagen: degradation by migrating endothelial cells. Science 1983; 221: 281283.
  • 9
    Fessier LI, Duncan KG, Fessier JH, Salo T, Tryggvason K. Characterization of the procollagen IV cleavage products produced by a specific tumor collagenase. J Biol Chem 1984; 259: 97839789.
  • 10
    Welgus HG, Stricklin SP. Human skin fibroblast collagenase inhibitor: comparative studies in human connective tissue serum and ampiotic fluid. J Biol Chem 1983; 253: 1225912264.
  • 11
    Welgus HG, Jeffrey JJ, Eisen AZ, Roswit WT, Stricklin GP. Human skin fibroblast collagenase: interaction with collagen and collagenase inhibitor. Collagen Relat Res 1985; 5: 167179.
  • 12
    Goldberg GI, Strongin A, Collier IE, Genrich LT, Marnier BI. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase and activation of the proenzyme with stromelysin. J Biol Chem 1992; 267: 45834591.
  • 13
    Goldberg GI, Marnier BL, Grant GA, Eisen AZ, Wilhelm S, He C. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc Natl Acad Sci U S A 1989; 86: 82078211.
  • 14
    Boone TC, Johnson MJ, DeClerck YA, Langley KE. CDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinase. Proc Natl Acad Sci U S A 1990; 87: 28002804.
  • 15
    Howard EW, Bullen EC, Banda MJ. Preferential inhibition of 72 kDa and 92 kDa gelatinases by TIMP-2. J Biol Chem 1991; 266: 1307013075.
  • 16
    Rao JS, Steck PA, Mohanam S, Stetler-Stevenson WG, Liotta LA, Sawaya K. Elevated levels of Mr 92,000 type IV collagenase in human brain tumors. Cancer Res 1993; 53: 22082211.
  • 17
    Sato H, Kida Y, Mai M, Endo Y, Sasaki T, Tanaka J, Seiki M. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 1992; 7: 7783.
  • 18
    Tsuchiya Y, Endo Y, Sato H, Okada Y, Mai M, Sasaki T, Seiki M. Expression of type-IV collagenases in human tumor cell lines that can form liver colonies in chick embryos. Int. Cancer 1994; 56: 4651.
  • 19
    Liotta LA, Steeg PS, Stethor-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991; 64: 327336.
  • 20
    Nakajima M, Lotan D, Baig M, Carralero RM, Wood WR, Hendrix MJC, Lotan R. Inhibition of retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells. Cancer Res 1989; 49: 16981706.
  • 21
    Gorbisa S, Pozzatti R, Muschel R, Saffioti U, Ballin M, Goldfarb R, Khonry G. et al. Secretion of type IV collagenolytic protease and metastatic pheno-type: induction by transfection with C-Ha-ras but not c-Ha-ras plus AdZ-Ela. Cancer Res 1987; 47: 15231528.
  • 22
    Ura H, Bonfil RD, Reich R, Reddel R, Pfeifer A, Harris CC, Klein JP. Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive and metastatic abilities of oncogene-transfected human bronchial epithelial cells. Cancer Res 1989; 49: 46154621.
  • 23
    Reich R, Thompson W, Iwamoto Y, Martin GR, Deason JR, Fuller GC, Miskin R. Effects of inhibitors of plasminogen activator, serine proteases and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res 1988; 48: 33073312.
  • 24
    Arii S, Tanaka J, Yamazoe Y, Minematsu S, Morino T, Fujita K, Maetani S. et al. Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy. Cancer 1992; 69: 913919.
  • 25
    Arii S, Tobe T. Results of surgical treatment: follow up study by liver cancer study group of Japan. In: TobeT, KamedaH, OkudairaM. et al. eds. Primary liver cancer in Japan. Tokyo: Springer-Verlag, 1992: 243255.
  • 26
    The Liver Cancer Study Group of Japan. Predictive factors for long term prognosis after partial hepatectomy for patients with hapatocellular carcinoma in Japan. Primary Liver Cancer Jpn 1994; 74: 27722780.
  • 27
    Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48900 necropsies. Cancer 1954; 7: 462503.
  • 28
    Wilhelm SM, Collier IE, Marnier BL, Eisen AZ, Grant GA, Goldberg GI. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 1989; 264: 1721317221.
  • 29
    Docherty AJP, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJR. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 1985; 318: 6669.
  • 30
    Stetler-Stevenson WG, Brown PD, Onisato M, Levy AT, Liotta LA. Tissue inhibitor of metalloproteinases (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 1990; 265: 1393313948.
  • 31
    Marchuk D, Drumm M, Saulino A, Collins FS. Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products. Nucleic Acids Res 1990; 19: 1154.
  • 32
    Louise SV, Marty L, Fort P. S26 ribosomal protein RNA. an invariant control for gene regulation experiments in eucaryotic cells and tissues. Nucleic Acids Res 1993; 21: 1498.
  • 33
    Sato H, Kida Y, Mai M, Endo Y, Sasaki T, Tanaka J, Seiki M. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 1992; 7: 7783.
  • 34
    Okada Y, Tsuchiya H, Shimizu H, Tomita K, Nakanishi I, Sato H, Seiki M. et al. Induction and stimulation of 92-KDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor α. Biochem Biophys Res Commun 1990; 171: 610617.
  • 35
    Davies B, Brown PD, East N, Crimmin MJ, Balkwill FR. A synthetic Matrix metalloproteinase inhibitor decreases tumor border and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res 1993; 53: 20872091.
  • 36
    Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 1994; 370: 6165.
  • 37
    Hicks NJ, Ward RV, Reynolds JJ. A fibrosarcoma model derived from mouse embryo cells: growth properties and secretion of collagenase and metalloproteinase inhibitor (TIMP) by tumor cell lines. Cancer 1984; 33: 835844.
  • 38
    Schultz RM, Silberman S, Persky B, Bajkowski AS, Carmichael DF. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16–F10. Cancer Res 1988; 48: 55395545.
  • 39
    Khokha R, Waterhouse P, Yagel S, Lala PK, Overall CM, Norton G, Denhardt DT. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3 T3 cells. Science 1989; 243: 947950.